Xu et al. found that cyclin D1 overexpression impacts the prognosis of ER-positive breast cancer patients, but not patients with unselected primary breast cancer or patients treated with neoadjuvant chemotherapy[30]. The gene discussed is CCND1; the disease is breast cancer.